2006
DOI: 10.1248/bpb.29.1010
|View full text |Cite
|
Sign up to set email alerts
|

Preparation of Neocarzinostatin Apoprotein Mutants and the Randomized Library on the Chromophore-Binding Cavity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
3
0

Year Published

2008
2008
2018
2018

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 26 publications
0
3
0
Order By: Relevance
“…Among the synthetic ligands, EtBr exhibits a relatively high binding constant (8.57 × 10 −7 M) [32] and has been frequently used to examine the binding properties of NCS mutants [37,38]. NMR study also suggests that the EtBr binds to the NCS protein in the same cleft where the natural enediyne chromophore binds [32].…”
Section: Thermal Stability Of Ncs Protein With and Without Etbrmentioning
confidence: 99%
“…Among the synthetic ligands, EtBr exhibits a relatively high binding constant (8.57 × 10 −7 M) [32] and has been frequently used to examine the binding properties of NCS mutants [37,38]. NMR study also suggests that the EtBr binds to the NCS protein in the same cleft where the natural enediyne chromophore binds [32].…”
Section: Thermal Stability Of Ncs Protein With and Without Etbrmentioning
confidence: 99%
“…F-41, which has ever been performed preliminary observation as antitumor candidate. 18,19) The NCS is a 1 : 1 noncovalent complex of an apoprotein and a chromophore, in which the chromophore plays the antitumor activity by DNA damaging activity. 18,20) The higher efficacy of enediyne antibiotics has intrigued intensive researches on cancer inhibition.…”
mentioning
confidence: 99%
“…18,19) The NCS is a 1 : 1 noncovalent complex of an apoprotein and a chromophore, in which the chromophore plays the antitumor activity by DNA damaging activity. 18,20) The higher efficacy of enediyne antibiotics has intrigued intensive researches on cancer inhibition. However, for most enediyne antibiotics, although the strong biological activities, especially anticancer capacity can be observed, their application are often limited by high toxicity and also low efficacy in vivo.…”
mentioning
confidence: 99%